Expression of Stem Cell Markers and Dopamine D2 Receptors in Human and Rat Prolactinomas

BACKGROUND: Dopamine agonists (DAs) are the first-line treatment for prolactinomas. DAs primarily target the dopamine D2 receptor (D2R). Tumor stem-like cells (TSLCs) are associated with the tolerance to radiotherapy and chemotherapy. TSLCs have also been identified in pituitary adenomas. We aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Zhichao, Cai, Lin, Lu, Jianglong, Wang, Chengde, Li, Qun, Chen, Jian, Song, Xiaoxiao, Chen, Xianbin, Zhang, Linlin, Zheng, Weiming, Su, Zhipeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Lab/In Vitro Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402840/
https://www.ncbi.nlm.nih.gov/pubmed/28411401
http://dx.doi.org/10.12659/MSM.901154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402840/
https://www.ncbi.nlm.nih.gov/pubmed/28411401
http://dx.doi.org/10.12659/MSM.901154

Ejemplares similares